KINESYS PHARMACEUTICALS INC
15-12G, 2000-10-26
PHARMACEUTICAL PREPARATIONS
Previous: VA LINUX SYSTEMS INC, 10-K405, EX-27.1, 2000-10-26
Next: COHEN & STEERS INSTITUTIONAL REALTY SHARES INC, N-30B-2, 2000-10-26



<PAGE>   1
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 15

     CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
   12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
  REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

                                        Commission File Number   000-27571

             KINESYS PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

             3771 Jacombs Road, Unit 415, Richmond, BC, Canada V6V2L9
--------------------------------------------------------------------------------
  (Address, including zip code, and telephone number, including area code, of
                   registrant's principal executive offices)

                                  Common Stock
--------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      None
--------------------------------------------------------------------------------
  (Titles of all other classes of securities for which a duty to file reports
                     under section 13(a) or 15(d) remains)

   Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

     Rule 12g-4(a)(1)(i)     [x]         Rule 12h-3(b)(1)(i)     [x]
     Rule 12g-4(a)(1)(ii)    [ ]         Rule 12h-3(b)(1)(ii)    [ ]
     Rule 12g-4(a)(2)(i)     [ ]         Rule 12h-3(b)(2)(i)     [ ]
     Rule 12g-4(a)(2)(ii)    [ ]         Rule 12h-3(b)(2)(ii)    [ ]
                                         Rule 15d-6              [ ]

   Approximate number of holders of record as of the certification or notice
date:  125

   Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of
registrant as specified in charter) has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.

Date: October 20, 2000             By: /s/ JEFF KLETTER, PRESIDENT
     ------------------                --------------------------------
                                           JEFF KLETTER, PRESIDENT

Instruction: This form is required by Rules 12g-4, 12h-3 and 15h-3 and 15d-6 of
the General Rules and Regulations under the Securities Exchange Act of 1934.
The registrant shall file with the Commission three copies of Form 15, one of
which shall be manually signed. It may be signed by an officer of the
registrant, by counsel or by any other duly authorized person. The name and
title of the person signing the form shall be typed or printed under the
signature.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission